Simpson, David
2 papers on CoChatORCID 0000-0002-9768-7413
Most cited papers
- Verified
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
van Rhee, F., Wong, R. S., Munshi, N., Rossi, J.-F., Ke, X.-Y., Fosså, A., Simpson, D., Capra, M., Liu, T., Hsieh, R. K., et al. (2014) · The Lancet Oncology
Viral-associated cancers and disordersLymphadenopathy Diagnosis and Analysis
Cited by 454
- Verified
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
Usmani, S. Z., Schjesvold, F., Oriol, A., Karlin, L., Cavo, M., Rifkin, R. M., Yimer, H. A., LeBlanc, R., Takezako, N., McCroskey, R. D., et al. (2019) · The Lancet Haematology
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 251
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free